» Articles » PMID: 36934429

Prognostic Risk Factor of Major Salivary Gland Carcinomas and Survival Prediction Model Based on Random Survival Forests

Overview
Journal Cancer Med
Specialty Oncology
Date 2023 Mar 19
PMID 36934429
Authors
Affiliations
Soon will be listed here.
Abstract

Salivary gland malignancies are rare and are often acompanied by poor prognoses. So, identifying the populations with risk factors and timely intervention to avoid disease progression is significant. This study provides an effective prediction model to screen the target patients and is helpful to construct a cost-effective follow-up strategy. We enrolled 249 patients diagnosed with salivary gland tumors and analyzed prognostic risk factors using Cox proportional hazard univariable and multivariable regression models. The patients' data were split into training and validation sets on a 7:3 ratio, and the random survival forest (RSF) model was established using the training sets and validated using the validation sets. The maximally selected rank statistics method was used to determine a cut point value corresponding to the most significant relation with survival. Univariable Cox regression suggested age, smoking, alcohol consumption, untreated, neural invasion, capsular invasion, skin invasion, tumors larger than 4 cm, advanced T and N stage, distant metastasis, and non-mucous cell carcinoma were risk factors for poor prognosis, and multivariable analysis suggested that female, aging, smoking, untreated, and non-mucous cell carcinoma were risk factors. The time-dependent ROC curve showed the AUC of the RSF prediction model on 1-, 2-, and 3-year survival were 0.696, 0.779, and 0.765 respectively in the validation sets. Log-rank tests suggested that the cut point 7.42 risk score calculated from the RSF was most effective in dividing patients with significantly different prognoses. The prediction model based on the RSF could effectively screen patients with poor prognoses.

Citing Articles

Prognosing post-treatment outcomes of head and neck cancer using structured data and machine learning: A systematic review.

Moharrami M, Azimian Zavareh P, Watson E, Singhal S, Johnson A, Hosni A PLoS One. 2024; 19(7):e0307531.

PMID: 39046953 PMC: 11268644. DOI: 10.1371/journal.pone.0307531.


Genetic Rearrangements in Different Salivary Gland Tumors: A Systematic Review.

Albalawi E Cureus. 2024; 16(6):e61639.

PMID: 38966479 PMC: 11223175. DOI: 10.7759/cureus.61639.


Machine learning-based survival prediction nomogram for postoperative parotid mucoepidermoid carcinoma.

Huang Z, Chen Z, Li Y, Lin T, Cai S, Wu W Sci Rep. 2024; 14(1):7686.

PMID: 38561379 PMC: 10985107. DOI: 10.1038/s41598-024-58329-8.


Predicting mortality and recurrence in colorectal cancer: Comparative assessment of predictive models.

Alinia S, Asghari-Jafarabadi M, Mahmoudi L, Roshanaei G, Safari M Heliyon. 2024; 10(6):e27854.

PMID: 38515707 PMC: 10955293. DOI: 10.1016/j.heliyon.2024.e27854.


PTEN Deregulation Mechanisms in Salivary Gland Carcinomas.

Papanikolaou V, Chrysovergis A, Adamopoulou M, Spyropoulou D, Roukas D, Papanastasiou G Cancer Diagn Progn. 2024; 4(1):25-29.

PMID: 38173659 PMC: 10758848. DOI: 10.21873/cdp.10280.


References
1.
Chen Y, Li G, Jiang W, Nie R, Deng H, Chen Y . Prognostic risk factor of major salivary gland carcinomas and survival prediction model based on random survival forests. Cancer Med. 2023; 12(9):10899-10907. PMC: 10225223. DOI: 10.1002/cam4.5801. View

2.
Oliveira L, Soave D, Oliveira-Costa J, Zorgetto V, Ribeiro-Silva A . Prognostic factors in patients with malignant salivary gland neoplasms in a Brazilian population. Asian Pac J Cancer Prev. 2011; 12(2):363-8. View

3.
Spitz M, BATSAKIS J . Major salivary gland carcinoma. Descriptive epidemiology and survival of 498 patients. Arch Otolaryngol. 1984; 110(1):45-9. DOI: 10.1001/archotol.1984.00800270049013. View

4.
Lee Y, Bang H, Kim D . How to Establish Clinical Prediction Models. Endocrinol Metab (Seoul). 2016; 31(1):38-44. PMC: 4803559. DOI: 10.3803/EnM.2016.31.1.38. View

5.
Steyerberg E, Vergouwe Y . Towards better clinical prediction models: seven steps for development and an ABCD for validation. Eur Heart J. 2014; 35(29):1925-31. PMC: 4155437. DOI: 10.1093/eurheartj/ehu207. View